Oct 04, 2023 8:30am EDT Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
Sep 06, 2023 8:00am EDT Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference
Jul 31, 2023 8:35am EDT Sigyn Therapeutics to Present at the OTCQB Venture Virtual Investor Conference on August 3rd
May 17, 2023 7:00am EDT Sigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark Application
Apr 11, 2023 8:30am EDT Sigyn Therapeutics™ Announces Appointment of Annette Marleau, Ph.D. as Chief Scientific Officer
